Identification of a high-affinity receptor for interleukin 1 alpha and interleukin 1 beta on cultured human rheumatoid synovial cells. 1988

J Chin, and E Rupp, and P M Cameron, and K L MacNaul, and P A Lotke, and M J Tocci, and J A Schmidt, and E K Bayne
Department of Biochemistry and Molecular Biology, Merck Sharp & Dohme Research Laboratories, Rahway, New Jersey 07065.

In this report the binding of recombinant human interleukins 1 alpha and 1 beta (rIL-1 alpha and rIL-1 beta) to primary cultures of human rheumatoid synovial cells is measured and compared to the concentrations of these mediators required for stimulation of PGE2 production by these same cells. The average concentration of IL-1 alpha required for half-maximal stimulation of PGE2 was 4.6 +/- 1.5 pM (+/- SEM) (n = 6), whereas for IL-1 beta half-maximal stimulation was observed at a concentration of 1.3 +/- 0.24 pM (n = 6). Both direct and competitive binding experiments were performed. In direct binding experiments, IL-1 alpha bound with a Kd of 66 pM (n = 1), while IL-1 beta bound with a Kd of 4 pM (n = 2). In competitive binding experiments, IL-1 alpha inhibited binding of 125I-IL-1 alpha with a Ki of 33-36 pM (n = 2) and binding of 125I-IL-1 beta with a Ki of 51-63 pM (n = 2). IL-1 beta inhibited binding of 125I-IL-1 alpha with a Ki of 2-3 pM (n = 2) and binding of 125I-IL-1 beta with a Ki of 7 pM (n = 2). The binding data were best fit by a model specifying a single class of receptors with homogeneous affinity for either IL-1 alpha or IL-1 beta and with an abundance of 3,000-14,000 sites per cell. Autoradiography showed that the vast majority of the synoviocytes within the cultures possessed IL-1 receptors. Comparison of biological response curves with the binding curves indicates that the observed receptors exhibit sufficiently high affinity to mediate the response of human synoviocytes to low picomolar concentrations of IL-1 alpha and IL-1 beta.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011971 Receptors, Immunologic Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. Immunologic Receptors,Immunologic Receptor,Immunological Receptors,Receptor, Immunologic,Receptors, Immunological
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D001345 Autoradiography The making of a radiograph of an object or tissue by recording on a photographic plate the radiation emitted by radioactive material within the object. (Dorland, 27th ed) Radioautography
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D013583 Synovial Membrane The inner membrane of a joint capsule surrounding a freely movable joint. It is loosely attached to the external fibrous capsule and secretes SYNOVIAL FLUID. Synovium,Membrana Synovialis Capsulae Articularis,Membrane, Synovial,Membranes, Synovial,Synovial Membranes

Related Publications

J Chin, and E Rupp, and P M Cameron, and K L MacNaul, and P A Lotke, and M J Tocci, and J A Schmidt, and E K Bayne
October 1988, Biochemical and biophysical research communications,
J Chin, and E Rupp, and P M Cameron, and K L MacNaul, and P A Lotke, and M J Tocci, and J A Schmidt, and E K Bayne
February 1990, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
J Chin, and E Rupp, and P M Cameron, and K L MacNaul, and P A Lotke, and M J Tocci, and J A Schmidt, and E K Bayne
January 1987, Rheumatology international,
J Chin, and E Rupp, and P M Cameron, and K L MacNaul, and P A Lotke, and M J Tocci, and J A Schmidt, and E K Bayne
April 1995, Annals of the rheumatic diseases,
J Chin, and E Rupp, and P M Cameron, and K L MacNaul, and P A Lotke, and M J Tocci, and J A Schmidt, and E K Bayne
April 1990, Acta endocrinologica,
J Chin, and E Rupp, and P M Cameron, and K L MacNaul, and P A Lotke, and M J Tocci, and J A Schmidt, and E K Bayne
October 1992, Clinical immunology and immunopathology,
J Chin, and E Rupp, and P M Cameron, and K L MacNaul, and P A Lotke, and M J Tocci, and J A Schmidt, and E K Bayne
May 1988, The Biochemical journal,
J Chin, and E Rupp, and P M Cameron, and K L MacNaul, and P A Lotke, and M J Tocci, and J A Schmidt, and E K Bayne
May 1987, Arthritis and rheumatism,
J Chin, and E Rupp, and P M Cameron, and K L MacNaul, and P A Lotke, and M J Tocci, and J A Schmidt, and E K Bayne
May 1994, Arthritis and rheumatism,
J Chin, and E Rupp, and P M Cameron, and K L MacNaul, and P A Lotke, and M J Tocci, and J A Schmidt, and E K Bayne
January 1993, Agents and actions. Supplements,
Copied contents to your clipboard!